G01N 33/535
With enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
Official title: with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates}
G01N33/535 (With enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates) appears on 509 US grants and 303 published applications in this corpus.
Search patents in G01N- Granted patents
- 509
- Published applications
- 303
- Assignees
- 267
- Inventors
- 1,064
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 13 | 0 |
| 1981 | 15 | 0 |
| 1982 | 9 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 7 | 0 |
| 1986 | 8 | 0 |
| 1987 | 15 | 0 |
| 1988 | 12 | 0 |
| 1989 | 14 | 0 |
| 1990 | 10 | 0 |
| 1991 | 5 | 0 |
| 1992 | 17 | 0 |
| 1993 | 17 | 0 |
| 1994 | 14 | 0 |
| 1995 | 12 | 0 |
| 1996 | 21 | 0 |
| 1997 | 36 | 0 |
| 1998 | 43 | 0 |
| 1999 | 18 | 0 |
| 2000 | 16 | 0 |
| 2001 | 19 | 5 |
| 2002 | 15 | 15 |
| 2003 | 5 | 18 |
| 2004 | 9 | 16 |
| 2005 | 9 | 12 |
| 2006 | 5 | 9 |
| 2007 | 5 | 9 |
| 2008 | 2 | 3 |
| 2009 | 6 | 8 |
| 2010 | 4 | 7 |
| 2011 | 3 | 8 |
| 2012 | 1 | 7 |
| 2013 | 7 | 6 |
| 2014 | 8 | 7 |
| 2015 | 8 | 11 |
| 2016 | 6 | 13 |
| 2017 | 8 | 9 |
| 2018 | 2 | 12 |
| 2019 | 4 | 17 |
| 2020 | 13 | 18 |
| 2021 | 10 | 25 |
| 2022 | 11 | 19 |
| 2023 | 10 | 17 |
| 2024 | 7 | 12 |
| 2025 | 4 | 8 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Luciferase linked immunosorbent assay6 Oct 2026US 12,753,245 B2Institut Pasteur
- Cell-free expression of antibodies, antigen-binding fragments thereof, and antibody derivatives7 Jul 2026US 12,674,799 B2Northwestern University
- Conjugate for immunodetection based on lateral flow assay, and immunodetection method using same14 Apr 2026US 12,601,737 B2Gmd Biotech, Inc.
- Reagent kit containing polypeptide for use in detection of intermolecular interactions17 Mar 2026US 12,578,329 B2Shimadzu Corporation
- Self-contained apparatus and system for detecting microorganisms24 Feb 2026US 12,560,603 B2Laboratory Corporation of America Holdings
- 3d-printed crispr diagnostic devices and uses thereof8 Oct 2026US 2026/0309703 A1University of Connecticut
- Covalent target engagement27 Aug 2026US 2026/0251633 A1Promega Corporation
- Derivatives, immunogens, and antibodies and use of the same in detection of ecstasy-class compounds13 Aug 2026US 2026/0234121 A1Siemens Healthcare Diagnostics Inc.
- Enzyme linked immunoassay with diffusion rate limiting medium13 Aug 2026US 2026/0234690 A1Elleon Biotech Limited
- Method for measuring antigen contained in test sample, and kit for measuring human chorionic gonadotropin or estradiol6 Aug 2026US 2026/0227417 A1FUJIFILM Corporation
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Method and structures employing chemically-labelled polynucleotide probes400US 4,994,373 AEnzo Biochem, Inc. · 1991
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Modified avidin-biotin technique288US 5,281,521 AThe Trustees of the University of Pennsylvania · 1994